The medical media is reporting Immunotherapy as a breakthrough in science, but in reality it has been around since the creation of humanity.  Immunotherapy is the new buzz word for what  attempts to resolve a disease by inducing, enhancing, or suppressing an immune response.

God created immunotherapy when the Great Physician made 1/5 of your body immune cells to protect you from what seeks to harm you.  Immunotherapies such as MG Beta 1,3/1,6 glucan are classified as cell-based activation immunotherapies and work by amplifying the immune response of Immune effector cells such as macrophages.

Immune effector cells including lymphocytes, macrophages, dendritic cells, natural killer cells and cytotoxic T cells (kill with chemicals) work together to defend the body against pathogens seeking to harm your health, including the focus of many today on cancer, by targeting abnormal antigens (a form of name tag) expressed on the surface of tumor cells. 

In plain language, your immune response and the healthy immune cells in all human bodies are created to protect us all from what seeks to harm us in our individual body’s by the immunotherapy of being able to recognize, respond, and resolve by first killing and then removing dead cells killed from the body.


Research from a decade ago published in the Journal of Immunology stated, “…beta-glucan, an agent without evident toxicity, may be used to amplify tumor cell killing and may open new opportunities in the immunotherapy of cancer.”  Ten years later immunotherapy, including beta glucan, is the overnight sensation that’s been around supported by scientific research for a decade and with specific receptors for intake in the human body since creation!

Researchers now recognize immunomodulatory regimens often also have fewer side effects than existing drugs associated with chemotherapy and radiation.  Understanding how the immune system works is opening the doors to developing new approaches that are changing the way we think about and react to resolving cancer.

A published research study in May of 2016 (Baert K, et al, PMC 4898424) reported “β-glucan microparticles (GPs) are emerging microparticles known for their safety, immunogenicity, and high antigen encapsulation efficiency.”  The immunogenicity of beta glucan from the cell wall of Saccharomyces Cerevisiae, such as the micronized microparticulate NSC MG beta glucan, refers to the ability of beta glucan to provoke or enable an immune response in the body of a human or animal.


In the scientific research of immunotherapy, the active agents of immunotherapy are collectively called immunomodulators. Included are an extensive group including recombinant, synthetic and natural preparations, often cytokines (small proteins important for cell signaling), Among the most important are granulocyte colony stimulating factor (G-CSF), interferons, imiquimod and various cellular membrane fractions from bacteria. Glucans are being researched in conjunction with the new monoclonal antibody delivery systems to target specific cancer cells in clinical and preclinical studies.

Immunomodulatory regimens acting alone or as an adjuvant to monoclonal antibodies often have fewer side effects than existing drugs, including less potential for creating recognition and response avoidance in microbial disease. The recommended beta 1,3/1,6 glucan is MG Beta Glucan from the Nutritional Scientific Corporation available either wholesale or retail in products including NSC-100 Extra Strength MG Glucan 60 ct and NSC-24 Original MG Glucan 30 ct.  For detailed label and content information click on the individual NSC product and then on Supplement Facts.  To learn more about the immune response go to www.immuneresponse.org.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.